3'-Methoxyflavonol

CAS No. 76666-32-5

3'-Methoxyflavonol( —— )

Catalog No. M21419 CAS No. 76666-32-5

3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
25MG 29 In Stock
50MG 38 In Stock
100MG 52 In Stock
200MG 74 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3'-Methoxyflavonol
  • Note
    Research use only, not for human use.
  • Brief Description
    3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).
  • Description
    3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).
  • In Vitro
    3'-Methoxyflavonol (NRA 10) is a selective agonist of neuromedin U 2 receptor (NMU2R).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    NMU2R
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    76666-32-5
  • Formula Weight
    268.26
  • Molecular Formula
    C16H12O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:155 mg/mL (577.8 mM and warming)
  • SMILES
    COC1=CC=CC(=C1)C2=C(C(=O)C3=CC=CC=C3O2)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ma ML et al. Design synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor. Bioorg Med Chem. 2014 Nov 1;22(21):6117-23.
molnova catalog
related products
  • (6S ,7S ,8S )-5,6,7,...

    6,7,8-Trihydroxy-2-(2-Phenethyl) chromone is a chromone derivative with anti-inflammatory effects.

  • UDP-Glucose sodium s...

    UDP-Glucose sodium salt is an endogenous nucleotide sugar involved in glycosyltransferase reactions in metabolism. It is an agonist of the P2Y14 receptor (EC50 = 0.35 μM). It can also bind to and activate GPR17 inducing oligodendrocyte differentiation at a maximal concentration of 100 μM.

  • Bivatuzumab

    Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.